002432 九安医疗
2024/09 - 九个月
人民幣(K¥)
与去年同期
比较
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)
2020/12
人民幣(K¥)
营业总收入2,092,0593,231,12526,315,3612,397,0982,008,360
减:营业总成本1,411,0852,186,3117,434,7301,447,6841,572,994
    其中:营业成本592,4771,176,5725,367,195875,549877,505
               财务费用9,514(199,522)(209,149)2,60218,784
               资产减值损失(8,723)(309,867)(321,559)(9,274)(177,698)
公允价值变动收益593,446309,288(326,401)30,489(335,946)
投资收益542,894560,73893,48345,583317,541
    其中:对联营企业和合营企业的投资收益--(1,679)(1,266)(1,380)(332)
营业利润1,817,5691,613,49118,311,8691,002,549238,588
利润总额1,817,1321,580,34418,257,857999,632239,753
减:所得税费用283,555231,1121,773,76365,2292,925
净利润1,533,5761,349,23216,484,094934,403236,828
减:非控股权益164,93597,624453,92525,761(5,501)
股东净利润1,368,6421,251,60816,030,169908,642242,329

市场价值指针
每股收益 (元) *3.1872.81535.1381.9990.560
每股派息 (元) *--0.3002.5000.7000.060
每股净资产 (元) *39.30839.38140.3575.9674.355
审计意见 #--标准的无保留意见标准的无保留意见标准的无保留意见
回页顶
备注: *未调整数据
#只提供简体内容